Format

Send to

Choose Destination
Int J Mol Sci. 2015 Apr 29;16(5):9772-93. doi: 10.3390/ijms16059772.

Changing the face of kynurenines and neurotoxicity: therapeutic considerations.

Author information

1
MTA-SZTE Neuroscience Research Group, Semmelweis u. 6, Szeged H-6725, Hungary. zsuzsanna.bohar@gmail.com.
2
MTA-SZTE Neuroscience Research Group, Semmelweis u. 6, Szeged H-6725, Hungary. toldi@bio.u-szeged.hu.
3
Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Közép fasor 52, Szeged H-6726, Hungary. toldi@bio.u-szeged.hu.
4
Institute of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Szeged, Eötvös utca 6, Szeged H-6720, Hungary. fulop@pharm.u-szeged.hu.
5
MTA-SZTE Neuroscience Research Group, Semmelweis u. 6, Szeged H-6725, Hungary. vecsei.laszlo@med.u-szeged.hu.
6
Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center University of Szeged, Semmelweis u. 6, Szeged H-6725, Hungary. vecsei.laszlo@med.u-szeged.hu.

Abstract

Kynurenines are the products of tryptophan metabolism. Among them, kynurenine and kynurenic acid are generally thought to have neuroprotective properties, while 3-hydroxykynurenine, 3-hydroxyanthranilic acid and quinolinic acid are considered neurotoxic. They participate in immunoregulation and inflammation and possess pro- or anti-excitotoxic properties, and their involvement in oxidative stress has also been suggested. Consequently, it is not surprising that kynurenines have been closely related to neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis and multiple sclerosis. More information about the less-known metabolites, picolinic and cinnabarinic acid, evaluation of new receptorial targets, such as aryl-hydrocarbon receptors, and intensive research on the field of the immunomodulatory function of kynurenines delineated the high importance of this pathway in general homeostasis. Emerging knowledge about the kynurenine pathway provides new target points for the development of therapeutical solutions against neurodegenerative diseases.

PMID:
25938971
PMCID:
PMC4463617
DOI:
10.3390/ijms16059772
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center